8-K Announcements
6Material company update
Mar 26, 2026·SEC
Material company update
Mar 20, 2026·SEC
Material company update
Feb 19, 2026·SEC
Zynex, Inc.(ZYXI)Earnings, Financials & Key Ratios
ZYXI•NASDAQ
$0.06
$2M mkt cap·0.6× P/E·Price updated Apr 28, 2026
AboutZynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.Show more
- Revenue$192M+4.4%
- EBITDA$11M-28.2%
- Net Income$3M-69.2%
- EPS (Diluted)0.09-66.7%
- Gross Margin79.5%+0.4%
- EBITDA Margin5.6%-31.2%
- Operating Margin3.11%-46.8%
- Net Margin1.56%-70.5%
- ROE7.32%-57.7%
- ROIC6.09%-43.2%
- Debt/Equity2.07+25.2%
- Interest Coverage2.52-79.8%
ZYXI Key Insights
Zynex, Inc. (ZYXI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 33.4%
- ✓Good 3Y average ROE of 16.3%
- ✓Share count reduced 10.6% through buybacks
- ✓Trading at only 0.0x book value
- ✓Efficient asset utilization: 1.6x turnover
✗Weaknesses
- ✗High debt to equity ratio of 2.1x
- ✗Profits declining 20.6% over 5 years
- ✗Weak momentum: RS Rating 5 (bottom 5%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
ZYXI Price & Volume
Zynex, Inc. (ZYXI) stock price & volume — 10-year historical chart
Loading chart...
ZYXI Growth Metrics
Zynex, Inc. (ZYXI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years32.99%
5 Years33.44%
3 Years13.86%
TTM-44.13%
Profit CAGR
10 Years-
5 Years-20.61%
3 Years-44.06%
TTM-1633.13%
EPS CAGR
10 Years-
5 Years-18.48%
3 Years-39.18%
TTM-1741.28%
Return on Capital
10 Years179.4%
5 Years17.26%
3 Years12.38%
Last Year5.36%
ZYXI Peer Comparison
Zynex, Inc. (ZYXI) competitors in Home Health Equipment and Supplies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 STIM | 132.9M | 1.91 | -3.24 | 99.17% | -24.48% | -139.83% | 3.44 | |
 ENVA | 4.3B | 172.57 | 14.90 | 18.58% | 24.88% | 3.41 | ||
 GMED | 12.07B | 89.22 | 22.76 | 16.65% | 18.3% | 12.4% | 0.03 | |
 ABT | 149.97B | 86.25 | 11.29 | 4.59% | 31.88% | 27.26% | 0.32 | |
 MDT | 99.48B | 77.60 | 21.50 | 3.62% | 13% | 9.45% | 0.59 | |
 BSX | 83.23B | 56.00 | 28.87 | 19.87% | 14.4% | 12.4% | 0.51 | |
 SYK | 111.96B | 292.33 | 34.80 | 11.16% | 12.92% | 15.04% | 0.66 | |
 LIVN | 3.62B | 66.26 | -14.89 | 10.74% | 7.47% | 9.13% | 0.39 |
Compare ZYXI vs Peers
Zynex, Inc. (ZYXI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ZYXI Income Statement
Zynex, Inc. (ZYXI) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 13.31M | 23.43M | 31.92M | 45.47M | 80.12M | 130.3M | 158.17M | 184.32M | 192.35M | 108.2M |
| Revenue Growth % | 14.36% | 76.01% | 36.21% | 42.47% | 76.2% | 62.63% | 21.39% | 16.54% | 4.36% | -44.13% |
| Cost of Goods Sold | 3.52M | 4.82M | 6.04M | 8.81M | 17.42M | 26.92M | 32.01M | 38.37M | 39.43M | 30.69M |
| COGS % of Revenue | 26.42% | 20.57% | 18.92% | 19.38% | 21.74% | 20.66% | 20.23% | 20.81% | 20.5% | - |
| Gross Profit | 9.8M▲ 0% | 18.61M▲ 90.0% | 25.88M▲ 39.0% | 36.66M▲ 41.7% | 62.7M▲ 71.1% | 103.38M▲ 64.9% | 126.16M▲ 22.0% | 145.96M▲ 15.7% | 152.93M▲ 4.8% | 77.51M▲ 0% |
| Gross Margin % | 73.58% | 79.43% | 81.08% | 80.62% | 78.26% | 79.34% | 79.77% | 79.19% | 79.5% | 71.64% |
| Gross Profit Growth % | 46.12% | 90.01% | 39.04% | 41.65% | 71.05% | 64.87% | 22.04% | 15.69% | 4.77% | - |
| Operating Expenses | 9.16M | 9.67M | 15.51M | 25.59M | 52.46M | 81.01M | 103.22M | 135.18M | 146.94M | 145.42M |
| OpEx % of Revenue | 68.77% | 41.26% | 48.59% | 56.28% | 65.47% | 62.17% | 65.26% | 73.34% | 76.39% | - |
| Selling, General & Admin | 9.16M | 9.67M | 15.51M | 25.59M | 52.46M | 77.46M | 103.22M | 135.18M | 146.94M | 114.68M |
| SG&A % of Revenue | 68.77% | 41.26% | 48.59% | 56.28% | 65.47% | 59.45% | 65.26% | 73.34% | 76.39% | - |
| Research & Development | 256K | 100K | 200K | 600K | 0 | 2.6M | 0 | 0 | 0 | 12M |
| R&D % of Revenue | 1.92% | 0.43% | 0.63% | 1.32% | - | 2% | - | - | - | - |
| Other Operating Expenses | -204K | 0 | 0 | 880K | 0 | 949K | 0 | 0 | 0 | 0 |
| Operating Income | 640K▲ 0% | 8.94M▲ 1297.5% | 10.37M▲ 15.9% | 11.07M▲ 6.7% | 10.25M▼ 7.4% | 22.37M▲ 118.2% | 22.94M▲ 2.6% | 10.78M▼ 53.0% | 5.99M▼ 44.4% | -67.91M▲ 0% |
| Operating Margin % | 4.81% | 38.17% | 32.49% | 24.34% | 12.79% | 17.16% | 14.5% | 5.85% | 3.11% | -62.76% |
| Operating Income Growth % | 125.8% | 1297.5% | 15.94% | 6.71% | -7.38% | 118.23% | 2.56% | -53% | -44.43% | - |
| EBITDA | 1.07M | 9.23M | 10.82M | 11.84M | 11.82M | 24.65M | 26.07M | 15M | 10.77M | -64.31M |
| EBITDA Margin % | 8.07% | 39.39% | 33.89% | 26.05% | 14.75% | 18.92% | 16.48% | 8.14% | 5.6% | -59.44% |
| EBITDA Growth % | 152.26% | 758.6% | 17.2% | 9.48% | -0.19% | 108.54% | 5.73% | -42.45% | -28.19% | -580.71% |
| D&A (Non-Cash Add-back) | 435K | 286K | 448K | 778K | 1.57M | 2.29M | 3.13M | 4.22M | 4.78M | 3.6M |
| EBIT | 640K | 8.94M | 10.37M | 11.07M | 10.17M | 22.37M | 22.64M | 13.67M | 6.01M | -67.91M |
| Net Interest Income | -352K | -1.45M | -154K | -5K | -19K | -95K | -440K | -1.09M | -2.38M | -3.04M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 352K | 1.45M | 154K | 5K | 19K | 95K | 440K | 1.09M | 2.38M | 3.04M |
| Other Income/Expense | -556K | -1.45M | -154K | 875K | -96K | -95K | -740K | 1.8M | -2.36M | -3.04M |
| Pretax Income | 84K▲ 0% | 7.49M▲ 8821.4% | 10.22M▲ 36.3% | 11.94M▲ 16.9% | 10.15M▼ 15.0% | 22.27M▲ 119.4% | 22.2M▼ 0.3% | 12.58M▼ 43.3% | 3.63M▼ 71.2% | -70.95M▲ 0% |
| Pretax Margin % | 0.63% | 31.98% | 32.01% | 26.26% | 12.67% | 17.09% | 14.03% | 6.82% | 1.89% | -65.57% |
| Income Tax | 15K | 129K | 664K | 2.45M | 1.08M | 5.17M | 5.15M | 2.85M | 633K | 3.01M |
| Effective Tax Rate % | 17.86% | 1.72% | 6.5% | 20.51% | 10.63% | 23.21% | 23.2% | 22.63% | 17.45% | -4.24% |
| Net Income | 69K▲ 0% | 7.37M▲ 10573.9% | 9.55M▲ 29.7% | 9.49M▼ 0.6% | 9.07M▼ 4.4% | 17.1M▲ 88.5% | 17.05M▼ 0.3% | 9.73M▼ 42.9% | 2.99M▼ 69.2% | -73.96M▲ 0% |
| Net Margin % | 0.52% | 31.43% | 29.93% | 20.87% | 11.33% | 13.13% | 10.78% | 5.28% | 1.56% | -68.35% |
| Net Income Growth % | 102.37% | 10573.91% | 29.69% | -0.63% | -4.4% | 88.48% | -0.32% | -42.91% | -69.24% | -1633.13% |
| Net Income (Continuing) | 69K | 7.37M | 9.55M | 9.49M | 9.07M | 17.1M | 17.05M | 9.73M | 2.99M | -73.96M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -89K | -89K | -89K | -89K | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.00▲ 0% | 0.20▲ 9900.0% | 0.26▲ 30.0% | 0.25▼ 3.8% | 0.24▼ 4.0% | 0.40▲ 66.7% | 0.44▲ 10.0% | 0.27▼ 38.6% | 0.09▼ 66.7% | -2.44▲ 0% |
| EPS Growth % | 102.36% | - | 30% | -3.85% | -4% | 66.67% | 10% | -38.64% | -66.67% | -1741.28% |
| EPS (Basic) | 0.00 | 0.21 | 0.27 | 0.27 | 0.24 | 0.41 | 0.44 | 0.27 | 0.09 | - |
| Diluted Shares Outstanding | 34.4M | 36.52M | 37.45M | 37.36M | 38.44M | 43.12M | 39.13M | 36.14M | 32.3M | 30.31M |
| Basic Shares Outstanding | 34.4M | 35.37M | 35.75M | 35.68M | 37.26M | 42.15M | 38.47M | 35.55M | 31.94M | 30.31M |
| Dividend Payout Ratio | - | - | - | 23.83% | - | 0.01% | 21.19% | 0.03% | 0.3% | - |
ZYXI Balance Sheet
Zynex, Inc. (ZYXI) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 3.42M | 8.37M | 14.33M | 22.57M | 63.02M | 82.69M | 69.56M | 87.86M | 75.18M | 37.02M |
| Cash & Short-Term Investments | 247K | 5.57M | 10.13M | 14.04M | 39.17M | 42.61M | 20.14M | 44.58M | 39.63M | 13.26M |
| Cash Only | 247K | 5.57M | 10.13M | 14.04M | 39.17M | 42.61M | 20.14M | 44.58M | 39.63M | 13.26M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3.03M | 2.19M | 2.79M | 5.83M | 13.84M | 28.63M | 35.06M | 26.84M | 18.02M | 6.7M |
| Days Sales Outstanding | 83.02 | 34.04 | 31.92 | 46.82 | 63.04 | 80.2 | 80.91 | 53.15 | 34.2 | 41.42 |
| Inventory | 107K | 423K | 837K | 2.38M | 8.63M | 10.76M | 13.48M | 13.11M | 13.92M | 11.99M |
| Days Inventory Outstanding | 11.1 | 32.04 | 50.6 | 98.48 | 180.96 | 145.83 | 153.78 | 124.69 | 128.85 | 153.59 |
| Other Current Assets | 0 | 0 | 0 | 315K | 1.38M | 689K | 868K | 3.33M | 0 | 5.07M |
| Total Non-Current Assets | 669K | 558K | 1.86M | 5.71M | 11.2M | 50.59M | 50.79M | 49.05M | 46.9M | 8.31M |
| Property, Plant & Equipment | 580K | 188K | 819K | 4.87M | 8.24M | 18.52M | 15.29M | 16.22M | 14.04M | 8M |
| Fixed Asset Turnover | 22.95x | 124.64x | 38.97x | 9.34x | 9.72x | 7.03x | 10.35x | 11.37x | 13.70x | 9.42x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 20.4M | 20.4M | 20.4M | 20.4M | 0 |
| Intangible Assets | 34K | 0 | 0 | 0 | 0 | 9.97M | 9.07M | 8.16M | 7.25M | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 55K | 370K | 314K | 329K | 347K | 974K | 591K | 409K | 5.21M | 8.39M |
| Total Assets | 4.09M▲ 0% | 8.93M▲ 118.3% | 16.18M▲ 81.3% | 28.28M▲ 74.7% | 74.22M▲ 162.5% | 133.27M▲ 79.6% | 120.35M▼ 9.7% | 136.9M▲ 13.8% | 122.08M▼ 10.8% | 45.32M▲ 0% |
| Asset Turnover | 3.25x | 2.62x | 1.97x | 1.61x | 1.08x | 0.98x | 1.31x | 1.35x | 1.58x | 1.21x |
| Asset Growth % | 10.69% | 118.26% | 81.25% | 74.72% | 162.49% | 79.56% | -9.7% | 13.75% | -10.83% | -123.24% |
| Total Current Liabilities | 7.75M | 4.01M | 6.36M | 5.2M | 10.12M | 22.87M | 21.09M | 18.53M | 16.86M | 78.85M |
| Accounts Payable | 2.88M | 2.25M | 1.55M | 2.13M | 4.72M | 4.74M | 5.6M | 8.43M | 7.09M | 12.52M |
| Days Payables Outstanding | 298.79 | 170.8 | 93.82 | 88.33 | 98.85 | 64.25 | 63.88 | 80.23 | 65.64 | 104.46 |
| Short-Term Debt | 2.77M | 231K | 0 | 1.26M | 2.13M | 8.31M | 7.94M | 0 | 0 | 63.77M |
| Deferred Revenue (Current) | 54K | 880K | -685K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 826K | 880K | 3.84M | 8K | 0 | 2.95M | 16K | 0 | 0 | 0 |
| Current Ratio | 0.44x | 2.08x | 2.25x | 4.34x | 6.23x | 3.62x | 3.30x | 4.74x | 4.46x | 4.46x |
| Quick Ratio | 0.43x | 1.98x | 2.12x | 3.88x | 5.38x | 3.15x | 2.66x | 4.03x | 3.63x | 3.63x |
| Cash Conversion Cycle | -204.66 | -104.72 | -11.3 | 56.97 | 145.14 | 161.78 | 170.82 | 97.6 | 97.41 | 90.55 |
| Total Non-Current Liabilities | 148K | 12K | 531K | 3.43M | 7.25M | 36.48M | 32.91M | 72.24M | 69.51M | 7.85M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 10.61M | 5.29M | 57.6M | 58.57M | 0 |
| Capital Lease Obligations | 136K | 0 | 2.98M | 3.43M | 5.2M | 16.17M | 13.73M | 14.64M | 10.94M | 37.52M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 2.05M | 4.81M | 3.88M | 0 | 0 | 1.94M |
| Other Non-Current Liabilities | 12K | 0 | 0 | 0 | 0 | 9.7M | 10M | 0 | 0 | 0 |
| Total Liabilities | 7.89M | 4.03M | 6.89M | 8.62M | 17.37M | 59.35M | 53.99M | 90.78M | 86.37M | 86.69M |
| Total Debt | 3.02M | 354K | 3.66M | 4.68M | 7.33M | 38.06M | 26.96M | 76.17M | 73.82M | 71.62M |
| Net Debt | 2.78M | -5.21M | -6.47M | -9.36M | -31.84M | -4.55M | 6.82M | 31.59M | 34.19M | 58.36M |
| Debt / Equity | - | 0.07x | 0.39x | 0.24x | 0.13x | 0.51x | 0.41x | 1.65x | 2.07x | 2.07x |
| Debt / EBITDA | 2.81x | 0.04x | 0.34x | 0.40x | 0.62x | 1.54x | 1.03x | 5.08x | 6.85x | -1.11x |
| Net Debt / EBITDA | 2.58x | -0.56x | -0.60x | -0.79x | -2.69x | -0.18x | 0.26x | 2.11x | 3.17x | 3.17x |
| Interest Coverage | 1.82x | 6.17x | 67.34x | 2213.20x | 535.37x | 235.43x | 51.45x | 12.50x | 2.52x | -22.32x |
| Total Equity | -3.8M▲ 0% | 4.9M▲ 228.9% | 9.3M▲ 89.7% | 19.65M▲ 111.4% | 56.85M▲ 189.3% | 73.92M▲ 30.0% | 66.36M▼ 10.2% | 46.13M▼ 30.5% | 35.71M▼ 22.6% | -41.37M▲ 0% |
| Equity Growth % | 6.61% | 228.93% | 89.68% | 111.37% | 189.29% | 30.02% | -10.24% | -30.48% | -22.59% | -371.64% |
| Book Value per Share | -0.11 | 0.13 | 0.25 | 0.53 | 1.48 | 1.71 | 1.70 | 1.28 | 1.11 | -1.36 |
| Total Shareholders' Equity | -3.71M | 4.99M | 9.39M | 19.74M | 56.85M | 73.92M | 66.36M | 46.13M | 35.71M | -41.37M |
| Common Stock | 31K | 33K | 34K | 34K | 36K | 41K | 39K | 33K | 32K | 30K |
| Retained Earnings | -9.78M | -2.41M | 4.87M | 14.36M | 23.43M | 0 | 17.05M | 26.78M | 29.77M | -43.57M |
| Treasury Stock | 0 | -243K | -3.67M | -3.85M | -3.85M | -6.51M | -33.16M | -71.56M | -87.19M | -92.12M |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -89K | -89K | -89K | -89K | 0 | 0 | 0 | 0 | 0 | 0 |
ZYXI Cash Flow Statement
Zynex, Inc. (ZYXI) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 1.7M | 8.26M | 9.41M | 6.3M | 818K | 6.95M | 13.75M | 17.76M | 12.72M | 12.72M |
| Operating CF Margin % | 12.77% | 35.25% | 29.48% | 13.86% | 1.02% | 5.33% | 8.69% | 9.63% | 6.61% | - |
| Operating CF Growth % | 398.53% | 385.88% | 13.9% | -33% | -87.02% | 749.51% | 97.81% | 29.17% | -28.36% | -1504.28% |
| Net Income | 69K | 7.37M | 9.55M | 9.49M | 9.07M | 17.1M | 17.05M | 9.73M | 2.99M | -73.96M |
| Depreciation & Amortization | 435K | 286K | 448K | 778K | 1.57M | 2.29M | 3.13M | 4.22M | 4.78M | 4.08M |
| Stock-Based Compensation | 200K | 66K | 370K | 820K | 2.68M | 1.63M | 2.34M | 2.3M | 2.99M | 2.1M |
| Deferred Taxes | 285K | 227K | -725K | 212K | -54K | -146K | -851K | -2.3M | -934K | 4.53M |
| Other Non-Cash Items | 200K | 1.48M | 370K | -695K | -236K | 1.29M | 1.18M | -2.08M | -1.05M | 30.07M |
| Working Capital Changes | 511K | -1.16M | -607K | -4.3M | -12.22M | -15.21M | -9.1M | 5.89M | 3.94M | 12.62M |
| Change in Receivables | -1.09M | 843K | -606K | -3.04M | -8M | -14.78M | -6.43M | 8.22M | 8.82M | 14.93M |
| Change in Inventory | 198K | -316K | -414K | -2.36M | -7.32M | -3.78M | -4.32M | -1.45M | -2.74M | 2.53M |
| Change in Payables | 402K | -1.22M | -515K | 1.02M | 3.03M | 2.89M | 1.83M | 269K | -2.07M | -3.18M |
| Cash from Investing | -174K | -87K | -1.08M | -160K | -985K | -16.61M | -418K | -966K | -578K | -431K |
| Capital Expenditures | -226K | -87K | -1.08M | -160K | -985K | -609K | -418K | -1.21M | -578K | -431K |
| CapEx % of Revenue | 1.7% | 0.37% | 3.39% | 0.35% | 1.23% | 0.47% | 0.26% | 0.65% | 0.3% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | -16M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -174K | 0 | 0 | 0 | 0 | 0 | 0 | 50K | 0 | 0 |
| Cash from Financing | -1.3M | -2.85M | -3.76M | -2.23M | 25.3M | 13.1M | -35.8M | 7.64M | -17.09M | -3.37M |
| Debt Issued (Net) | -72K | -2.52M | -507K | -19K | -57K | 15.86M | -5.45M | 46.22M | -334K | 1.87M |
| Equity Issued (Net) | 0 | -183K | -3.26M | -171K | 25.2M | -2.51M | -26.38M | -38.66M | -15.63M | 9K |
| Dividends Paid | 0 | 0 | 0 | -2.26M | 0 | -1K | -3.61M | -3K | -9K | 0 |
| Share Repurchases | 0 | -377K | -3.43M | -171K | 0 | -2.67M | -26.43M | -37.92M | -15.63M | 0 |
| Other Financing | -1.23M | -155K | 0 | 221K | 154K | -252K | -352K | 86K | -1.12M | -5.25M |
| Net Change in Cash | 239K▲ 0% | 5.32M▲ 2125.1% | 4.56M▼ 14.2% | 3.91M▼ 14.3% | 25.13M▲ 542.5% | 3.44M▼ 86.3% | -22.47M▼ 753.3% | 24.43M▲ 208.8% | -4.95M▼ 120.2% | -24.37M▲ 0% |
| Free Cash Flow | 1.47M▲ 0% | 8.17M▲ 454.5% | 8.33M▲ 1.9% | 6.14M▼ 26.2% | -167K▼ 102.7% | 6.34M▲ 3896.4% | 13.33M▲ 110.2% | 16.55M▲ 24.2% | 12.14M▼ 26.6% | -21M▲ 0% |
| FCF Margin % | 11.07% | 34.88% | 26.09% | 13.51% | -0.21% | 4.87% | 8.43% | 8.98% | 6.31% | -19.41% |
| FCF Growth % | 332.26% | 454.48% | 1.87% | -26.22% | -102.72% | 3896.41% | 110.22% | 24.17% | -26.63% | -235.24% |
| FCF per Share | 0.04 | 0.22 | 0.22 | 0.16 | -0.00 | 0.15 | 0.34 | 0.46 | 0.38 | 0.38 |
| FCF Conversion (FCF/Net Income) | 24.64x | 1.12x | 0.98x | 0.66x | 0.09x | 0.41x | 0.81x | 1.82x | 4.25x | 0.28x |
| Interest Paid | 0 | 0 | 772K | 5K | 894K | 82K | 3.62M | 3.06M | 3M | 0 |
| Taxes Paid | 0 | 0 | 12K | 2.87M | 19K | 3.31M | 6.29M | 6.46M | 2.58M | 0 |
ZYXI Key Ratios
Zynex, Inc. (ZYXI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | 1339.09% | 134.54% | 65.57% | 23.72% | 26.16% | 24.31% | 17.3% | 7.32% | -1807.05% |
| Return on Invested Capital (ROIC) | - | - | 616.53% | 126.44% | 43.54% | 35.54% | 24.14% | 10.72% | 6.09% | 6.09% |
| Gross Margin | 73.58% | 79.43% | 81.08% | 80.62% | 78.26% | 79.34% | 79.77% | 79.19% | 79.5% | 71.64% |
| Net Margin | 0.52% | 31.43% | 29.93% | 20.87% | 11.33% | 13.13% | 10.78% | 5.28% | 1.56% | -68.35% |
| Debt / Equity | - | 0.07x | 0.39x | 0.24x | 0.13x | 0.51x | 0.41x | 1.65x | 2.07x | 2.07x |
| Interest Coverage | 1.82x | 6.17x | 67.34x | 2213.20x | 535.37x | 235.43x | 51.45x | 12.50x | 2.52x | -22.32x |
| FCF Conversion | 24.64x | 1.12x | 0.98x | 0.66x | 0.09x | 0.41x | 0.81x | 1.82x | 4.25x | 0.28x |
| Revenue Growth | 14.36% | 76.01% | 36.21% | 42.47% | 76.2% | 62.63% | 21.39% | 16.54% | 4.36% | -44.13% |
ZYXI SEC Filings & Documents
Zynex, Inc. (ZYXI) SEC filings — annual & quarterly reports (10-K, 10-Q)
ZYXI Frequently Asked Questions
Zynex, Inc. (ZYXI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Zynex, Inc. (ZYXI) reported $108.2M in revenue for fiscal year 2024. This represents a 871513% increase from $0.0M in 1998.
Zynex, Inc. (ZYXI) grew revenue by 4.4% over the past year. Growth has been modest.
Zynex, Inc. (ZYXI) reported a net loss of $74.0M for fiscal year 2024.
Dividend & Returns
Yes, Zynex, Inc. (ZYXI) pays a dividend with a yield of 0.51%. This makes it attractive for income-focused investors.
Zynex, Inc. (ZYXI) has a return on equity (ROE) of 7.3%. This is below average, suggesting room for improvement.
Zynex, Inc. (ZYXI) had negative free cash flow of $21.0M in fiscal year 2024, likely due to heavy capital investments.
Explore More ZYXI
Zynex, Inc. (ZYXI) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates